General Information:

Id: 3,101 (click here to show other Interactions for entry)
Diseases: Pseudomonas aeruginosa diseases
pathogen-host system
Pseudomonas aeruginosa/mammalia
P. aeruginosa strain P14
article
Reference: Lesic B et al.(2007) Inhibitors of pathogen intercellular signals as selective anti-infective compounds. PLoS Pathog. 3: 1229-1239 [PMID: 17941706]

Interaction Information:

Comment The halogenated AA (anthranilic acid) analogs 6FABA (2-amino-6-fluorobenzoic acid), 6CABA (2-amino-6-chlorobenzoic acid) and 4CABA (2-amino-4-chlorobenzoic acid) limit P. aeruginosa virulence in a thermal injury mice model.
Formal Description
Interaction-ID: 28461

drug/chemical compound

6FABA

decreases_activity of

process

P. aeruginosa infection

in a thermal injury mice model
Comment The halogenated AA (anthranilic acid) analogs 6FABA (2-amino-6-fluorobenzoic acid), 6CABA (2-amino-6-chlorobenzoic acid) and 4CABA (2-amino-4-chlorobenzoic acid) limit P. aeruginosa virulence in a thermal injury mice model.
Formal Description
Interaction-ID: 28462

drug/chemical compound

6CABA

decreases_activity of

process

P. aeruginosa infection

in a thermal injury mice model
Comment The halogenated AA (anthranilic acid) analogs 6FABA (2-amino-6-fluorobenzoic acid), 6CABA (2-amino-6-chlorobenzoic acid) and 4CABA (2-amino-4-chlorobenzoic acid) limit P. aeruginosa virulence in a thermal injury mice model.
Formal Description
Interaction-ID: 28463

drug/chemical compound

4CABA

decreases_activity of

process

P. aeruginosa infection

in a thermal injury mice model